Members of the billionaire Sackler family that own Purdue Pharma LP have offered to pay as much as $6 billion to revive the OxyContin maker’s imperiled opioid settlement, a more-than $1 billion increase from their existing proposal.

The U.S. Supreme Court will take up a contentious immigration clash, agreeing to decide whether President Joe Biden’s administration can end a Trump-era policy requiring asylum seekers at the southern border to wait in Mexico for their cases to be processed.

Rapidly climbing inflation in the U.S. is accelerating calls from governors and state leaders to provide immediate tax relief to cash-strapped residents facing higher prices on everyday products such as gas, milk, and electricity.

A group of immigrant investors is suing to force the Biden administration to process visas and adjustment of status applications in limbo since congressional authorization for an investor visa program expired last year.

Special counsel John Durham has spent a year longer investigating the origins of the Mueller report than Robert Mueller spent compiling it, filed 35 fewer indictments, and survived three attorneys general—with no end in sight.

A federal appeals court has dismissed litigation over the Biden administration’s controversial shot-or-test rule for large U.S. businesses.